Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24806754)

1.

Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.

Andress EJ, Nicolaou M, Romero MR, Naik S, Dixon PH, Williamson C, Linton KJ.

Hepatology. 2014 May;59(5):1921-31. doi: 10.1002/hep.26970. Epub 2014 Apr 1.

PMID:
24806754
2.

Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.

Goldschmidt ML, Mourya R, Connor J, Dexheimer P, Karns R, Miethke A, Sheridan R, Zhang K, Bezerra JA.

Hepatol Res. 2015 Jun 29. doi: 10.1111/hepr.12545. [Epub ahead of print]

PMID:
26126923
3.

ABCB4 Disease Presenting with Cirrhosis and Copper Overload-Potential Confusion with Wilson Disease.

Shneider BL.

J Clin Exp Hepatol. 2011 Sep;1(2):115-7. doi: 10.1016/S0973-6883(11)60131-X. Epub 2011 Nov 9.

4.

Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.

Morita SY, Terada T.

Biomed Res Int. 2014;2014:954781. doi: 10.1155/2014/954781. Epub 2014 Jul 15.

5.

Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.

Kunne C, de Graaff M, Duijst S, de Waart DR, Oude Elferink RP, Paulusma CC.

Lab Invest. 2014 Oct;94(10):1103-13. doi: 10.1038/labinvest.2014.102. Epub 2014 Jul 28.

PMID:
25068656
6.

ABCB4: Insights from pathobiology into therapy.

Falguières T, Aït-Slimane T, Housset C, Maurice M.

Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):557-63. doi: 10.1016/j.clinre.2014.03.001. Epub 2014 Jun 19. Review.

PMID:
24953525
7.

ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.

Jirsa M, Bronský J, Dvořáková L, Šperl J, Šmajstrla V, Horák J, Nevoral J, Hřebíček M.

World J Gastroenterol. 2014 May 21;20(19):5867-74. doi: 10.3748/wjg.v20.i19.5867.

8.

Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.

Gautherot J, Delautier D, Maubert MA, Aït-Slimane T, Bolbach G, Delaunay JL, Durand-Schneider AM, Firrincieli D, Barbu V, Chignard N, Housset C, Maurice M, Falguières T.

Hepatology. 2014 Aug;60(2):610-21. doi: 10.1002/hep.27170. Epub 2014 May 19.

PMID:
24723470
9.

Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.

Gordo-Gilart R, Andueza S, Hierro L, Martínez-Fernández P, D'Agostino D, Jara P, Alvarez L.

Gut. 2015 Jan;64(1):147-55. doi: 10.1136/gutjnl-2014-306896. Epub 2014 Mar 4.

PMID:
24594635
10.

The etiology of intrahepatic cholestasis of pregnancy: towards solving a monkey puzzle.

Webb GJ, Elsharkawy AM, Hirschfield GM.

Am J Gastroenterol. 2014 Jan;109(1):85-8. doi: 10.1038/ajg.2013.437.

PMID:
24402531
11.

Functional Characterization of ABCB4 Mutations Found in Low Phospholipid-Associated Cholelithiasis (LPAC).

Kim TH, Park HJ, Choi JH.

Korean J Physiol Pharmacol. 2013 Dec;17(6):525-30. doi: 10.4196/kjpp.2013.17.6.525. Epub 2013 Dec 16.

12.

A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy.

Dixon PH, Wadsworth CA, Chambers J, Donnelly J, Cooley S, Buckley R, Mannino R, Jarvis S, Syngelaki A, Geenes V, Paul P, Sothinathan M, Kubitz R, Lammert F, Tribe RM, Ch'ng CL, Marschall HU, Glantz A, Khan SA, Nicolaides K, Whittaker J, Geary M, Williamson C.

Am J Gastroenterol. 2014 Jan;109(1):76-84. doi: 10.1038/ajg.2013.406. Epub 2013 Dec 24.

13.

Molecular pathogenesis of chronic cholestatic liver disease: impact on novel therapeutic approaches.

Fickert P, Stieger B.

Mol Aspects Med. 2014 Jun;37:1-2. doi: 10.1016/j.mam.2013.11.001. Epub 2013 Nov 25. No abstract available.

PMID:
24287163
14.
15.

Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.

Degiorgio D, Corsetto PA, Rizzo AM, Colombo C, Seia M, Costantino L, Montorfano G, Tomaiuolo R, Bordo D, Sansanelli S, Li M, Tavian D, Rastaldi MP, Coviello DA.

Eur J Hum Genet. 2014 May;22(5):633-9. doi: 10.1038/ejhg.2013.214. Epub 2013 Sep 18.

16.

Cholestatic liver disease.

Jüngst C, Lammert F.

Dig Dis. 2013;31(1):152-4. doi: 10.1159/000347210. Epub 2013 Jun 17. Review.

PMID:
23797137
17.

Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.

Wang R, Liu L, Sheps JA, Forrest D, Hofmann AF, Hagey LR, Ling V.

Am J Physiol Gastrointest Liver Physiol. 2013 Aug 15;305(4):G286-94. doi: 10.1152/ajpgi.00082.2013. Epub 2013 Jun 13.

18.

A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.

Stindt J, Ellinger P, Weissenberger K, Dröge C, Herebian D, Mayatepek E, Homey B, Braun S, Schulte am Esch J, Horacek M, Canbay A, Schmitt L, Häussinger D, Kubitz R.

Liver Int. 2013 Nov;33(10):1527-35. doi: 10.1111/liv.12217. Epub 2013 Jun 12.

PMID:
23758865
19.

Detergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastoris.

Ellinger P, Kluth M, Stindt J, Smits SH, Schmitt L.

PLoS One. 2013 Apr 4;8(4):e60620. doi: 10.1371/journal.pone.0060620. Print 2013.

20.

The genetics of complex cholestatic disorders.

Hirschfield GM, Chapman RW, Karlsen TH, Lammert F, Lazaridis KN, Mason AL.

Gastroenterology. 2013 Jun;144(7):1357-74. doi: 10.1053/j.gastro.2013.03.053. Epub 2013 Apr 10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk